Quest Diagnostics
598 hedge funds and large institutions have $11.2B invested in Quest Diagnostics in 2016 Q4 according to their latest regulatory filings, with 91 funds opening new positions, 195 increasing their positions, 212 reducing their positions, and 42 closing their positions.
117% more first-time investments, than exits
New positions opened: 91 | Existing positions closed: 42
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
40% more call options, than puts
Call options by funds: $35.4M | Put options by funds: $25.2M
8% more capital invested
Capital invested by funds: $10.4B → $11.2B (+$868M)
7% more funds holding
Funds holding: 559 → 598 (+39)
0.43% less ownership
Funds ownership: 88.78% → 88.35% (-0.43%)
8% less repeat investments, than reductions
Existing positions increased: 195 | Existing positions reduced: 212
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
+$83.3M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
+$74.9M |
| 3 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$61.3M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$61M |
| 5 |
BG
BlackRock Group
London,
United Kingdom
|
+$52.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$95.7M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
-$87.8M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
-$65.3M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$58.8M |
| 5 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$56.5M |
DGX Hedge Fund Activity: Q4 2016 in Review
598 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q4 2016, worth a combined $11.2B — up 8.4% from $10.4B a quarter earlier.
Buyers outnumbered sellers: 91 funds opened new DGX positions and 42 closed out — a net gain of 49 holders — while 195 added to existing stakes and 212 trimmed.
The largest buyer was HealthCor Management, adding an estimated $83.3M. The largest seller was Capital International Investors, cutting an estimated $95.7M.
- 598 institutional investors held Quest Diagnostics (DGX) as of Q4 2016, up from 559 in Q3 2016.
- Funds reported $11.2B of Quest Diagnostics stock for Q4 2016, up 8.4% quarter-over-quarter.
- 91 funds opened new Quest Diagnostics positions in Q4 2016 and 42 closed out, a net change of +49 holders.
- The largest Quest Diagnostics buyer in Q4 2016 was HealthCor Management, an estimated $83.3M added.
- The largest Quest Diagnostics seller in Q4 2016 was Capital International Investors, an estimated $95.7M sold.
Based on aggregated 13F filings for Q4 2016.